Back to search

France· FR:67682145

FLAMMAZINE, crème

A medicinal product containing sulfadiazine argentique, registered in France by ALLIANCE PHARMA (IRLANDE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFLAMMAZINE, crèmeATC—REGISTER NO.FR:67682145PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SULFADIAZINE ARGENTIQUE
Manufacturer
ALLIANCE PHARMA (IRLANDE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400932070268
    1 tube(s) de 50 g
    EUR 3.33
  • cip13
    3400932070329
    1 pot(s) de 500 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulfadiazine argentique in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulfadiazine argentique products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Flammazine
  • Belgium · Flammazine
  • Bulgaria · Дермазин
  • Cyprus · Silvederma, Sylfio
  • Germany · Flammazine
  • Estonia · Sulfargin
  • Spain · Flammazine, Silvederma
  • United Kingdom (Northern Ireland) · Flamazine
  • Greece · Sylfio
  • Croatia · Dermazin
  • Hungary · Dermazin
  • Italy · Sofargen
  • Lithuania · Sulfargin
  • Luxembourg · Flammazine
  • Latvia · Sulfargin
  • Malta · Silvederma
  • Netherlands · Flammazine, Zilversulfadiazine Cf
  • Portugal · Flammazine
  • Romania · Dermazin, Regen-Ag
  • Slovenia · Dermazin
  • Slovakia · Dermazin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f380f187-0b55-4952-aea6-1b1e64a13ebc
GET /v1/drugs/f380f187-0b55-4952-aea6-1b1e64a13ebc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67682145",
  "date_amm": "1977-01-10",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SULFADIAZINE ARGENTIQUE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "crème",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about sulfadiazine argentique.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.